2 terminated, 1 completed, 1 withdrawn. 2 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Terminated 1 |
Follow Tissue Array Analysis: new trials by email Literature Review of Tissue Array Analysis trials Research Report on Tissue Array Analysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI Diagnostic (ferumoxytol-enhanced MRI), Surgery, Ferumoxytol - Childhood Brain Neoplasm | Early Phase 1 | Withdrawn | Michael Iv | 2017-07-01 | 2023-04-14 | |
| Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS Ferumoxytol, Tissue Analysis, Magnetic Resonance Imaging - Brain Injury, Central Nervous System Degenerative Disorder | Early Phase 1 | Completed | Michael Iv | 10 | 2015-06-10 | 2017-08-31 |
| FDG-PET in Advanced Melanoma [18F]fluorodeoxyglucose, Molecular assays on biopsied tissue, positron emission tomography - Recurrent Melanoma, Stage IIIA Melanoma | Not applicable | Terminated | Vanderbilt-Ingram Cancer Center | 3 | 2012-05-01 | 2017-04-13 |
| Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer DNA and tissue microarray analysis, reverse transcriptase-polymerase chain reaction, mass spectrometry - Head and Neck Cancer | Terminated | Vanderbilt-Ingram Cancer Center | 58 | 2007-04-01 | 2013-04-02 |
Brain Injuries (1) · Brain Neoplasms (1) · Central Nervous System Infections (1) · Central Nervous System Vascular Malformations (1) · Head and Neck Neoplasms (1) · Hemorrhagic Stroke (1) · Ischemic Stroke (1) · Melanoma (1) · Neurodegenerative Diseases (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Michael Iv (2) · Vanderbilt-Ingram Cancer Center (2)
United States (3)
Barbara Murphy, MD (1) · Michael Iv (1) · Michael Iv, MD (1) · Tom Yankeelov, PhD (1)
P30CA068485 (2), P30CA124435 (1)